The increased CLDN5/ZO1 ratio was evaluated in the patients hospitalized, less than 6 h after the onset of a stroke, discriminated between the groups of ischemic stroke patients with and without a hemorrhagic transformation. This evidence concerns the gene CLDN5 and stroke disorder.